Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia
Clinical trial NCT02834286 · UNKNOWN
Trial details
- NCT number
- NCT02834286
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2017-03-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.